An Open-Label, Multitumor, Phase Ii Basket Study Of Olaparib And Durvalumab (Mediola): Results In Germline Brca-Mutated (Gbrcam) Her2-Negative Metastatic Breast Cancer (Mbc)
CANCER RESEARCH（2018）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined